// Global Analysis Archive
A Hogan Lovells panel at the 2026 J.P. Morgan Healthcare Conference highlights that international expansion in life sciences is increasingly shaped by AI regulation, trade controls, and supply-chain security. The discussion points to faster PRC approval pathways alongside tighter data/genetic governance, and rising scrutiny of tariffs and country-of-origin representations in the U.S. and EU.
Chinese researchers introduced the Dongbi Index lists for medical and life-science journals as an alternative to impact-factor-centric evaluation. The initiative is viewed by some experts as supporting China’s broader push to strengthen its role in shaping academic evaluation standards.
A Hogan Lovells panel at the 2026 J.P. Morgan Healthcare Conference highlights that international expansion in life sciences is increasingly shaped by AI regulation, trade controls, and supply-chain security. The discussion points to faster PRC approval pathways alongside tighter data/genetic governance, and rising scrutiny of tariffs and country-of-origin representations in the U.S. and EU.
Chinese researchers introduced the Dongbi Index lists for medical and life-science journals as an alternative to impact-factor-centric evaluation. The initiative is viewed by some experts as supporting China’s broader push to strengthen its role in shaping academic evaluation standards.
| ID | Title | Category | Date | Views | |
|---|---|---|---|---|---|
| RPT-226 | JPM 2026 Briefing: Life Sciences Expansion Meets AI, Trade, and China Data Governance | Life Sciences | 2026-01-27 | 1 | ACCESS » |
| RPT-3232 | China Unveils Dongbi Index to Reframe Journal Influence Beyond Impact Factor | China | 2024-11-20 | 0 | ACCESS » |